2
Registered trials
0
Recruiting
1
Unique sponsors
1
Unique IMPs
2
Commercial trials
Drug classes (ATC)
—
ATC code not specified
2
Mechanism of action (INN-stem analysis)
Unknown / small molecule
1 substance
Phase III:
1
Phase II:
1
Phase III
1 trial-
EndedAbbVie Deutschland GmbH & Co. KG CommercialLINACLOTIDE
Phase II
1 trial-
EndedAbbVie Deutschland GmbH & Co. KG CommercialLINACLOTIDE
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| AbbVie Deutschland GmbH & Co. KG | Commercial | 2 | Phase II, Phase III | 0 |
New trials by year
2023
1
2024
1